Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare Inc (HCA) and Glaukos (GKOS)


Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on HCA Healthcare Inc (NYSE:HCA) and Glaukos (NYSE:GKOS).

HCA Healthcare Inc (HCA)

In a report released today, Matthew Borsch from BMO Capital maintained a Buy rating on HCA Healthcare Inc, with a price target of $155. The company’s shares closed yesterday at $134.03, close to its 52-week high of $138.18.

According to TipRanks.com, Borsch is a 3-star analyst with an average return of 3.6% and a 53.8% success rate. Borsch covers the Services sector, focusing on stocks such as Centene Corp, UnitedHealth, and Mednax Inc.

HCA Healthcare Inc has an analyst consensus of Strong Buy, with a price target consensus of $138.40, which is a 3.3% upside from current levels. In a report issued on August 31, Cantor Fitzgerald also maintained a Buy rating on the stock with a $135 price target.

.

See today’s analyst top recommended stocks >>

Glaukos (GKOS)

BMO Capital analyst Joanne Wuensch maintained a Hold rating on Glaukos today and set a price target of $68. The company’s shares closed yesterday at $67.50, close to its 52-week high of $70.91.

According to TipRanks.com, Wuensch is a 5-star analyst with an average return of 14.6% and a 74.2% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Baxter International, and Edwards Lifesciences.

Glaukos has an analyst consensus of Moderate Buy, with a price target consensus of $62.17.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts